Real-world data in the era of immune checkpoint inhibitors

被引：0
|
作者：
Narita, Yukiya [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-5
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [21] Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types
    Wang, Feicheng
    Yang, Shihao
    Palmer, Nathan
    Fox, Kathe
    Kohane, Isaac S.
    Liao, Katherine P.
    Yu, Kun-Hsing
    Kou, S. C.
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [22] Real-world data analyses unveiled the immune-related adverse effects of immune checkpoint inhibitors across cancer types
    Feicheng Wang
    Shihao Yang
    Nathan Palmer
    Kathe Fox
    Isaac S. Kohane
    Katherine P. Liao
    Kun-Hsing Yu
    S. C. Kou
    npj Precision Oncology, 5
  • [23] Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real-world retrospective analysis
    Zhou, Chengjing
    Jiang, Ting
    Li, Rongzhen
    Yuan, Yan
    Xie, Weihao
    Huang, Xiaoxue
    Wang, Qiaoxuan
    Chang, Hui
    Chen, Gong
    Li, Yuhong
    Zeng, Zhifan
    Xiao, Weiwei
    Gao, Yuanhong
    CANCER COMMUNICATIONS, 2021, 41 (09) : 921 - 924
  • [24] Autoimmune Hematological Toxicities of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Database Analysis
    Keerty, Dinesh
    Haddad, Philip A.
    Ramadas, Poornima
    Master, Samip R.
    BLOOD, 2022, 140 : 13160 - 13161
  • [25] From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults
    Loh, Kah Poh
    Wong, Melisa L.
    Maggiore, Ronald
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (03) : 385 - +
  • [26] Effect of immune checkpoint inhibitors in metastatic gastric cancer: A real-world evidence study
    Puccetti, F.
    Mazza, E.
    Hernandez-Ibarburu, G.
    Rusconi, F.
    Liscia, N.
    Barbieri, L. A.
    Treppiedi, E.
    Cossu, A.
    Rosati, R.
    Elmore, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S880 - S880
  • [27] BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience
    Rihawi, Karim
    Giannarelli, Diana
    Galetta, Domenico
    Delmonte, Angelo
    Giavarra, Marco
    Turci, Daniele
    Garassino, Marina
    Tiseo, Marcello
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : E57 - E59
  • [28] Hyperprogression on immune checkpoint inhibitors: A single institution, real-world retrospective analysis.
    Paydary, Koosha
    Moturi, Krishna Rekha
    Baral, Binav
    Farooq, Muhammad Zain
    Lad, Thomas E.
    Mangla, Ankit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Efficacy and safety of immune checkpoint inhibitors in older HCC patients: A real-world study
    Cheng, J.
    Chen, B.
    Lu, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S338 - S338
  • [30] Hematologic and lymphatic system toxicities associated with immune checkpoint inhibitors: a real-world study
    Li, Na
    Feng, Yong
    Chen, Xiaoling
    Li, Ye
    Zhang, Chengmiao
    Yin, Yin
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345